Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): Can they predict malignancy?

World Journal of Surgery

Volumn 34, Issue 12, 2010, Pages 3022-3028

  Agarwal, Amit ^a   Mehrotra, Prateek K ^a   Jain, Manoj ^a   Gupta, Sushil K ^a   Mishra, Anjali ^a   Chand, Gyan ^a   Agarwal, Gaurav ^a   Verma, A K ^a   Mishra, S K ^a   Singh, Uttam ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL GLAND; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHEOCHROMOCYTOMA; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHEOCHROMOCYTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 78651319969     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0744-5     Document Type: Article

References (17)

1. Kim HH, Kim GH, Sung GT (2004) Laparoscopic adrenalectomy for pheochromocytoma: comparison with conventional open adrenalectomy. J Endourol 18(3):251-255
2. Davies MJ, McGlade DP, Banting SW (2004) A comparison of open and laparoscopic approaches to adrenalectomy in patients with phaeochromocytoma. Anaesth Intensive Care 32(2):224-229
3. Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE, Gauger PG (2003) Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134(6):918-922 discussion 922-923
4. Thompson LD (2002) Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26(5):551-566
5. Wu D, Tischler AS, Lloyd RV, DeLellis RA, de Krijger R, van Nederveen F et al (2009) Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 33(4):599-608
6. Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, FongY et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143(6):759-768
7. Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134(2):181-185
8. Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW III, Oates JA et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229(6):755- 764 discussion 764-766
9. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison EG Jr (1974) Current management of pheochromocytoma. Ann Surg 179(5):740-748
10. van Heerden JA, Roland CF, Carney JA, Sheps SG, Grant CS (1990) Long-term evaluation following resection of apparently benign pheochromocytoma(s)/ paraganglioma(s). World J Surg 14(3):325-329
11. Proye C, Vix M, Goropoulos A, Kerlo P, Lecomte-Houcke M (1992) High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 15(9):651-663
12. Proye CA, Vix M, Jansson S, Tisell LE, Dralle H, Hiller W (1994) "The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J Surg 18(4):467-472
13. O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA (1996) Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20(7):916-921
14. Linnoila RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21(11):1168-1180
15. Nativ O, Grant CS, Sheps SG, O'Fallon JR, Farrow GM, van Heerden JA et al (1992) Prognostic profile for patients with pheochromocytoma derived from clinical and pathological factors and DNA ploidy pattern. J Surg Oncol 50(4):258-262
16. John H, Ziegler WH, Hauri D, Jaeger P (1999) Pheochromocytomas: can malignant potential be predicted? Urology 53(4):679-683
17. Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK (2005) Normotensive pheochromocytoma: institutional experience. World J Surg 29(9):1185-1188